Wagner M, Goetghebeur M, Merikle E, Pandya A, Chu P, Taylor DC. COST- EFFECTIVENESS OF INTENSIVE LIPID LOWERING THERAPY WITH 80 MG OF ATORVASTATIN, VERSUS 10 MG OF ATORVASTATIN, FOR SECONDARY PREVENTION OF CARDIOVASCULAR DISEASE IN CANADA. J Popl Ther Clin Pharmacol. 2018;16(2). Accessed September 21, 2025. https://jptcp.com/index.php/jptcp/article/view/549